ClinVar Miner

Submissions for variant NM_000257.4(MYH7):c.1013T>A (p.Val338Glu)

dbSNP: rs397516087
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 1
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Agnes Ginges Centre for Molecular Cardiology, Centenary Institute RCV000584807 SCV000692497 uncertain significance Hypertrophic cardiomyopathy 2018-08-22 criteria provided, single submitter research The MYH7 Val338Glu variant is novel. It is absent from the Genome Aggregation Database (http://gnomad.broadinstitute.org/). We have identified this variant in a HCM proband that was diagnosed in childhood. In a large HCM population study Walsh et al., showed that MYH7 variants identified in HCM cases were found to cluster between amino acids 181- 937 (2017), this implies that variants in this region are likely to cause a HCM phenotype. Interestingly, rare variants at this position (Val338Ala & Val338Met) have been reported in HCM cases and Val338Met has been classified as 'likely pathogenic'. Computational tools SIFT, PolyPhen-2 and MutationTaster predict this variant to have a deleterious effect. Based on the adapted ACMG guidelines (Kelly MA, et al., 2018) this variant is located in a known functional domain of MYH7 (PM1), is rare in the general population (PM2) and in silico tools predict the variant to be deleterious (PP3), therefore we classify MYH7 Val338Glu as a variant of 'uncertain significance'.

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.